Annual report for Rubra Medicaments Ltd. for FY-2021
29-06-2021
RUBRA MEDICAMENTS LTD. - 531099 - Board Meeting Intimation for The Meeting Of Board Of Directors Of The Company Will Be Held On Tuesday, June 29, 2021
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2021 ,inter alia, to consider and approve the Standalone Audited Financial Results of the Company for the quarter and year ended March 31, 202115-06-2021
Rubra Medicaments Ltd - 531099 - Compliance Certificate Under Regulation 40(10) - March 2021
Compliance Certificate under Regulation 40(10) - March 202120-04-2021
Rubra Medicaments Ltd - 531099 - Compliance Certificate For The Half Year Ended March 31, 2021
Compliance Certificate for the half year ended March 31, 202115-04-2021
RUBRA MEDICAMENTS LTD. - 531099 - Appointment Mr. Harish Surve As Independent Director
Appointment Mr. Harish Surve as Independent Director15-04-2021
RUBRA MEDICAMENTS LTD. - 531099 - Board Meeting Intimation for Appointment Of Independent Director
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/04/2021 ,inter alia, to consider and approve appointment of Independent Director07-04-2021
RUBRA MEDICAMENTS LTD. - 531099 - Shareholding for the Period Ended March 31, 2021
Rubra Medicaments Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here06-04-2021
Rubra Medicaments Ltd - 531099 - Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Abha KapoorDesignation :- Chief Financial Officer03-04-2021
Rubra Medicaments Ltd - 531099 - Closure of Trading Window
Intimation of closure of trading window31-03-2021
RUBRA MEDICAMENTS LTD. - 531099 - Outcome Of Board Meeting
To considered and approved the Unaudited Standalone Financial Results for the quarter ended December 31, 2020 along with the Limited Review Report.12-02-2021